These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Effect of carvedilol on exercise tolerance in patients with chronic heart failure and a restrictive left ventricular filling pattern. Al-Nasser F; Yousufuddin M; Al-Nozha F; Anker SD; Coats AJ; Piepoli MF; Ponikowski PP Am J Cardiol; 2003 May; 91(10):1281-3. PubMed ID: 12745124 [No Abstract] [Full Text] [Related]
4. Effect of carvedilol on left ventricular function and mass in hypertension. Why HJ; Richardson PJ J Cardiovasc Pharmacol; 1992; 19 Suppl 1():S50-4. PubMed ID: 1378151 [TBL] [Abstract][Full Text] [Related]
6. Left ventricular hypertrophy regression during antihypertensive treatment. Eichstaedt H; Danne O; Schroeder RJ; Kreuz D Clin Investig; 1992; 70 Suppl 1():S79-86. PubMed ID: 1350490 [TBL] [Abstract][Full Text] [Related]
7. Predicting response to carvedilol for the treatment of heart failure: a multivariate retrospective analysis. Schleman KA; Lindenfeld JA; Lowes BD; Bristow MR; Ferguson D; Wolfel EE; Abraham WT; Zisman LS J Card Fail; 2001 Mar; 7(1):4-12. PubMed ID: 11264544 [TBL] [Abstract][Full Text] [Related]
8. Carvedilol improves left ventricular function and symptoms in chronic heart failure: a double-blind randomized study. Olsen SL; Gilbert EM; Renlund DG; Taylor DO; Yanowitz FD; Bristow MR J Am Coll Cardiol; 1995 May; 25(6):1225-31. PubMed ID: 7722114 [TBL] [Abstract][Full Text] [Related]
9. A controlled study of the effects of carvedilol on clinical events, left ventricular function and proinflammatory cytokines levels in patients with dilated cardiomyopathy. Tatli E; Kurum T Can J Cardiol; 2005 Mar; 21(4):344-8. PubMed ID: 15838561 [TBL] [Abstract][Full Text] [Related]
10. [Complex ventricular arrhythmias and carvedilol: efficacy in hemodialyzed uremic patients]. Cice G; Tagliamonte E; Ferrara L; Di Benedetto A; Iacono A Cardiologia; 1998 Jun; 43(6):597-604. PubMed ID: 9675959 [TBL] [Abstract][Full Text] [Related]
11. Low-dose carvedilol improves left ventricular function and reduces cardiovascular hospitalization in Japanese patients with chronic heart failure: the Multicenter Carvedilol Heart Failure Dose Assessment (MUCHA) trial. Hori M; Sasayama S; Kitabatake A; Toyo-oka T; Handa S; Yokoyama M; Matsuzaki M; Takeshita A; Origasa H; Matsui K; Hosoda S; Am Heart J; 2004 Feb; 147(2):324-30. PubMed ID: 14760332 [TBL] [Abstract][Full Text] [Related]
12. Effects of carvedilol, a vasodilator-beta-blocker, in patients with congestive heart failure due to ischemic heart disease. Australia-New Zealand Heart Failure Research Collaborative Group. Circulation; 1995 Jul; 92(2):212-8. PubMed ID: 7600653 [TBL] [Abstract][Full Text] [Related]
13. Beta-blockade therapy in chronic heart failure: diastolic function and mitral regurgitation improvement by carvedilol. Capomolla S; Febo O; Gnemmi M; Riccardi G; Opasich C; Caporotondi A; Mortara A; Pinna GD; Cobelli F Am Heart J; 2000 Apr; 139(4):596-608. PubMed ID: 10740140 [TBL] [Abstract][Full Text] [Related]
14. Effects of carvedilol on plasma levels of pro-inflammatory cytokines in patients with ischemic and nonischemic dilated cardiomyopathy. Kurum T; Tatli E; Yuksel M Tex Heart Inst J; 2007; 34(1):52-9. PubMed ID: 17420794 [TBL] [Abstract][Full Text] [Related]
15. Five cases of anthracycline-induced cardiomyopathy effectively treated with carvedilol. Mukai Y; Yoshida T; Nakaike R; Mukai N; Iwato K; Kyo T; Kaseda S Intern Med; 2004 Nov; 43(11):1087-8. PubMed ID: 15609710 [TBL] [Abstract][Full Text] [Related]
16. Carvedilol produces sustained long-term benefits: follow-up at 12 years. MacGregor JF; Wachter SB; Munger M; Stoddard G; Bristow MR; Gilbert EM Congest Heart Fail; 2009; 15(1):5-8. PubMed ID: 19187400 [TBL] [Abstract][Full Text] [Related]
17. Pharmacology of carvedilol: rationale for use in hypertension, coronary artery disease, and congestive heart failure. Ruffolo RR; Feuerstein GZ Cardiovasc Drugs Ther; 1997 May; 11 Suppl 1():247-56. PubMed ID: 9211017 [TBL] [Abstract][Full Text] [Related]
18. Left ventricular diastolic function improvement by carvedilol therapy in advanced heart failure. Palazzuoli A; Quatrini I; Vecchiato L; Calabria P; Gennari L; Martini G; Nuti R J Cardiovasc Pharmacol; 2005 Jun; 45(6):563-8. PubMed ID: 15897784 [TBL] [Abstract][Full Text] [Related]
19. Effects of nebivolol versus carvedilol on left ventricular function in patients with chronic heart failure and reduced left ventricular systolic function. Lombardo RM; Reina C; Abrignani MG; Rizzo PA; Braschi A; De Castro S Am J Cardiovasc Drugs; 2006; 6(4):259-63. PubMed ID: 16913827 [TBL] [Abstract][Full Text] [Related]
20. Effects of carvedilol on systolic and diastolic left ventricular performance in idiopathic dilated cardiomyopathy or ischemic cardiomyopathy. Quaife RA; Gilbert EM; Christian PE; Datz FL; Mealey PC; Volkman K; Olsen SL; Bristow MR Am J Cardiol; 1996 Oct; 78(7):779-84. PubMed ID: 8857482 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]